Cargando…

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years

BACKGROUND: To quantify the benefits (cancer prevention and down-staging) and harms (recall and excess treatment) of cervical screening starting from age 20 years rather than from age 25 years. METHODS: We use routine screening and cancer incidence statistics from Wales (for screening from age 20 ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landy, R, Birke, H, Castanon, A, Sasieni, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974083/ https://www.ncbi.nlm.nih.gov/pubmed/24518600 http://dx.doi.org/10.1038/bjc.2014.65

Ejemplares similares

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
por: Sasieni, P, et al.
Publicado: (2003)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits
por: Berrington de González, A, et al.
Publicado: (2005)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years
por: Moss, S, et al.
Publicado: (2005)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study
por: Castanon, Alejandra, et al.
Publicado: (2021)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Benefit‐to‐harm ratio of the Danish breast cancer screening programme
por: Beau, Anna‐Belle, et al.
Publicado: (2017)

Cervical cancer mortality in Norway according to screening attendance and age
por: Baasland, Ingrid, et al.
Publicado: (2022)

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Should Cervical Cancer Screening be Performed Before the Age of 25 Years?
por: Moscicki, Anna-Barbara, et al.
Publicado: (2018)

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States
por: Landy, Rebecca, et al.
Publicado: (2019)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
por: Leinonen, M K, et al.
Publicado: (2013)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case–Control Study of Cervical Cancer
por: Green, J, et al.
Publicado: (2003)

Comparison of 1- and 2-year screening intervals for women undergoing screening mammography
por: Wai, E S, et al.
Publicado: (2005)

Cancer mortality in the United Kingdom: projections to the year 2025
por: Olsen, A H, et al.
Publicado: (2008)

Cancer incidence in the United Kingdom: projections to the year 2030
por: Mistry, M, et al.
Publicado: (2011)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age–period–cohort approach
por: Woo, P P S, et al.
Publicado: (2005)

Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE)
por: Akinyemiju, Tomi, et al.
Publicado: (2016)

Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
por: Kreusch, Teresa, et al.
Publicado: (2018)

Accidental poisoning, intentional self-harm and event of undetermined intent mortality over 20 years in Iceland: a population-based cohort study
por: Gunnarsdottir, Oddny Sigurborg, et al.
Publicado: (2020)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Screening mammography: benefit of double reading by breast density
por: Euler-Chelpin, My von, et al.
Publicado: (2018)

Gender differences in colorectal cancer: implications for age at initiation of screening
por: Brenner, H, et al.
Publicado: (2007)

Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
por: Inwald, EC, et al.
Publicado: (2017)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

The effect of age On cervical cancer screening in women aged 20-29
por: Tuncer, Hasan Aykut, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uqku1ugc5hnnm4mraggliahre0